[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556318":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":31,"centralContacts":35,"locations":40,"responsibleParty":57,"collaborators":10,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":43,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University Hospital, Montpellier","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Pregnant women",null,"Women who are pregnant between 7 and 16 weeks of amenorrhea (WA)",[13,14,15],"Procedure: Inclusion (Visit 1 - Week 7-16)","Diagnostic Test: Second semester of pregnancy (Visit 2 - Week 20-24)","Diagnostic Test: Third semester of pregnancy (Visit 3- Week 34)",[17,22,27],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"PROCEDURE","Inclusion (Visit 1 - Week 7-16)","Extraction of cervico-vaginal sampling",[9],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"DIAGNOSTIC_TEST","Second semester of pregnancy (Visit 2 - Week 20-24)","Ultrasound examination (determination of chromosomal sex)",[9],{"type":23,"name":28,"description":29,"armGroupLabels":30,"otherNames":10},"Third semester of pregnancy (Visit 3- Week 34)","Ultrasound examination (determination of chromosomal sex) if this has not be done during the Visit 2 or if a new determination correcting the previous one is provided.",[9],[32],{"name":33,"affiliation":5,"role":34},"Vincent GATINOIS, MD","PRINCIPAL_INVESTIGATOR",[36],{"name":33,"role":37,"phone":38,"phoneExt":10,"email":39},"CONTACT","0 67 33 68 66","v-gatinois@chu-montpellier.fr",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":45,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"CHU de Montpellier","RECRUITING","Montpellier","France","34295","FR",{"type":49,"coordinates":50},"Point",[51,52],3.87635,43.61093,{"lat":52,"lon":51},[55],{"name":56,"role":34,"phone":10,"phoneExt":10,"email":10},"Vincent GATINOIS, Dr",{"type":58,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100556318","ultra-early-identification-of-fetal-chromosomal-characteristics-from-extravillous-trophoblast-cells-100556318",false,"NCT06523543","Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells","CellF-Cervix","Inclusion Criteria:\n\n* Pregnant woman\n* Singleton pregnancy\n* Pregnancy between 7 and 16 weeks of amenorrhea (WA)\n* Woman ≥ 18 years\n* Woman who has signed an informed consent\n* Woman affiliated to social security or equivalent scheme\n\nExclusions Criteria:\n\n* Person under guardianship or curatorship\n* Person placed under legal protection\n* Person unable to provide the participant with informed consent.",true,"FEMALE","18 Years",{"count":70,"type":71},25,"ESTIMATED","OBSERVATIONAL","Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.",[75],"Pregnant Women",[77,78,79,80,81],"Trophoblast cells","Endocervical canal","Fluorescent in situ hybridization (FISH)","Non-invasive prenatal test","Fetal gender","2026-03-12",{"date":84,"type":85},"2026-03-13","ACTUAL",{"date":87,"type":85},"2024-11-19",{"date":89,"type":71},"2028-09-01",{"name":5,"class":6},1]